🔎 Trials Near Me

Beranda › Penyakit Parkinson › Maryland

Uji klinis Penyakit Parkinson di Maryland

15 studi untuk Penyakit Parkinson mencari peserta di lokasi di Maryland.

Kota di Maryland

Teks studi resmi (Bahasa Inggris)

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  • University of Maryland, Baltimore
Menerima pesertaFase 2
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06680830

Evaluation and Treatment of Neurosurgical Disorders

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 4 hingga 99 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT00060541

Deep Brain Stimulation Therapy in Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
Menerima peserta
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT02119611

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT04396873

Natural History Protocol for Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05413291

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #043, Baltimore
  • Vima Site #007, Olney
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07804615

Parkinson's Foundation PD GENEration Genetic Registry

  • Johns Hopkins, Baltimore
  • University of Maryland, College Park
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT04994015

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  • MedStar Montgomery Medical Center, Olney
Menerima pesertaStudi observasional
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07330258

Deep Brain Stimulation Surgery for Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
Menerima peserta
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT01581580

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  • Johns Hopkins Hospital - Neurology, Baltimore
Menerima pesertaFase 3
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06944522

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  • Johns Hopkins University, Baltimore
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT04477785

Effects of RAS on Gait in PD Patients With DBS

  • Johns Hopkins School of Medicine, Baltimore
Menerima peserta
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT05763732

First-in-Human Single and Multiple Dose of HL-400

  • Pharmaron CPC, Inc., Baltimore
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT06997484

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

  • University of Maryland, Baltimore, Baltimore
Menerima pesertaStudi observasional
Usia 30 hingga 99 · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT05539196

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

  • University of Maryland, Baltimore
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT06719583

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.